DJIA 15,349.41 -4.99 -0.03%
NASDAQ 3,499.37 0.40 0.01%
S&P 500 1,667.75 0.28 0.02%

3.12 -0.04 (-1.27%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

TSPT $3.12 -1.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.15
Previous Close $3.16
Daily Range $3.05 - $3.18
52-Week Range $3.05 - $7.45
Market Cap $58.5M
P/E Ratio -3.55
Dividend (Yield) $0.00 (0.0%)
Volume 66,341
Average Daily Volume 154,950
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

Transcept Pharmaceuticals (TSPT) Description

Transcept Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. Website: http://www.transcept.com/

News & Commentary Rss Feed

4 Biotechs' Dominant Moves

A closer look at today's big market movers

SmithOnStocks Opines On Stocks: May 19th Edition

Cheerleaders: Look Beyond Pharma For Jobs

Benzinga's Top Downgrades

Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Impax Beats Earnings Estimate - Analyst Blog

AMAG Narrows Loss; Maintains View - Analyst Blog

Merck - BMY in HCV Deal - Analyst Blog

Merck - BMY in HCV Deal - Analyst Blog

Merck In-Licenses from Xenon - Analyst Blog

Merck In-Licenses from Xenon - Analyst Blog

Sanofi's Vaccine Gets EU Approval - Analyst Blog

See More TSPT News...

TSPT's Top Competitors

TSPT $3.12 (-1.27%)
Current stock: TSPT
AMGN $102.04 (-3.40%)
Current stock: AMGN
GILD $55.84 (-0.82%)
Current stock: GILD
BIIB $225.30 (-0.68%)
Current stock: BIIB